Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 6 Neuroendocrine Tumors 5 Neoplasms 4 Breast Neoplasms 4 Esophageal Neoplasms 3 Stomach Neoplasms 2 Pancreatic Neoplasms 2 Lymphoma, Non-Hodgkin 2 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Urinary Bladder Neoplasms 1 Smoking Cessation 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Ductal Adenocarcinoma 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Nasopharyngeal Carcinoma 1 Multiple Pulmonary Nodules 1 Multiple Myeloma 1 Meningioma 1 Lymphoma, T-Cell 1 Lymphoma, B-Cell 1 Lymphoma 1 Liver Neoplasms 1 Leukemia, Myeloid, Acute 1 Large B-cell Lymphoma 1 Hypoxia 1 Hodgkin Disease 1 Hepatic Malignancies 1

Interventions

Paclitaxel 177 Carboplatin 177 Bevacizumab 72 Topotecan 55 liposomal doxorubicin 54 Gemcitabine 53 Cisplatin 46 Docetaxel 39 Cyclophosphamide 37 olaparib 32 Filgrastim 31 pembrolizumab 29 Doxorubicin 26 niraparib 24 Taxes 23 Drug Therapy 23 Peripheral Blood Stem Cell Transplantation 20 Etoposide 17 veliparib 15 Nivolumab 14 sargramostim 13 Surveys and Questionnaires 13 Immunoglobulin G 13 Disulfides 13 pazopanib 12 Ifosfamide 12 Albumin-Bound Paclitaxel 12 durvalumab 11 atezolizumab 11 Trabectedin 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Ovarian Neoplasms × Positron Emission Tomography Computed Tomography × Clear all

NCT02258165 2023-04-18

IMAGE

Queensland Centre for Gynaecological Cancer

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡